CLBT - Cellebrite DI Ltd.

QQQ $ 612.11 $ 7.61 (1.26 %)

DIA $ 467.12 $ 5.24 (1.13 %)

SPY $ 671.75 $ 6.91 (1.04 %)

TLT $ 91.68 $ 0.35 (0.38 %)

GLD $ 401.36 $ 14.16 (3.64 %)

Previous Close

$ 18.05

Open

$ 18.46

Bid

$ 17.75 x 100

Ask

$ 18.29 x 129

Day's Range

$ 17.88 - $ 18.52

52 Week Range

$ 13.10 - $ 26.30

Volume

1,286,226

Average Volume

Market Cap

4.32B

Beta (5Y Monthly)

$ 0.91

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

JP Morgan Maintains Overweight on Cellebri...
09/24/2025 12:30:36

JP Morgan analyst Brian Essex maintains Cellebrite DI (NASDAQ:CLBT) with a Overweight and raises the price target from $20 t...

applied-materials-to-rally-around-17-here-are-10-top-analyst-forecasts-for-friday

Applied Materials To Rally Around 17%? Her...
08/15/2025 15:14:00

Lake Street Maintains Buy on Cellebrite DI...
08/15/2025 15:06:53

Lake Street analyst Eric Martinuzzi maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $24 to...

Needham Maintains Buy on Cellebrite DI, Lo...
08/14/2025 17:44:14

Needham analyst Mike Cikos maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $24 to $18.

Cellebrite DI Sees Q3 Sales $121.000M-$126...
08/14/2025 11:03:05

Cellebrite DI (NASDAQ:CLBT) sees Q3 sales of $121.000 million-$126.000 million vs $124.357 million analyst estimate.

Cellebrite DI Lowers FY2025 Sales Guidance...
08/14/2025 11:02:54

Cellebrite DI (NASDAQ:CLBT) lowers FY2025 sales outlook from $470.000 million-$485.000 million to $465.000 million-$475.000 mil...

Cellebrite DI Q2 Adj. EPS $0.12 Beats $0.1...
08/14/2025 11:00:51

Cellebrite DI (NASDAQ:CLBT) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.10 b...

Earnings Scheduled For August 14, 2025
08/14/2025 08:32:32

Cellebrite Announces U.S. DOJ Will Serve A...
07/23/2025 12:33:34

Cellebrite Appoints David Barter CFO, Effe...
07/08/2025 12:37:08

Needham Reiterates Buy on Cellebrite DI, M...
06/06/2025 11:16:01

Needham analyst Mike Cikos reiterates Cellebrite DI (NASDAQ:CLBT) with a Buy and maintains $24 price target.

Cellebrite Agrees To Acquire Corellium For...
06/05/2025 11:32:56

Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today ...

Needham Maintains Buy on Cellebrite DI, Lo...
05/14/2025 17:57:38

Needham analyst Mike Cikos maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $28 to $24.

dow-edges-higher-us-crude-oil-inventories-increase

Dow Edges Higher; US Crude Oil Inventories...
05/14/2025 16:15:42

Cellebrite DI Sees Q2 Sales $110.000M-$116...
05/14/2025 11:02:42

Cellebrite DI (NASDAQ:CLBT) sees Q2 sales of $110.000 million-$116.000 million vs $115.34 million analyst estimate.

Cellebrite DI Lowers FY2025 Sales Guidance...
05/14/2025 11:02:28

Cellebrite DI (NASDAQ:CLBT) lowers FY2025 sales outlook from $480.00 million-$490.00 million to $470.00 million-$485.00 million...

Cellebrite DI Q1 Adj. EPS $0.10 Beats $0.0...
05/14/2025 11:00:45

Cellebrite DI (NASDAQ:CLBT) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.08 b...

Earnings Scheduled For May 14, 2025
05/14/2025 08:32:23

JP Morgan Maintains Overweight on Cellebri...
05/12/2025 18:04:02

JP Morgan analyst Brian Essex maintains Cellebrite DI (NASDAQ:CLBT) with a Overweight and lowers the price target from $29 t...

Needham Reiterates Buy on Cellebrite DI, M...
04/02/2025 11:56:14

Needham analyst Mike Cikos reiterates Cellebrite DI (NASDAQ:CLBT) with a Buy and maintains $28 price target.